UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage from type 1 diabetes.
Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.
The Michael J Fox Foundation for Parkinson’s Research awards grant to Grifols for pioneering study
Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying ...
Researchers at UVA have developed computer models to create targeted antibiotics, aiming to combat antibiotic resistance.
Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.
Discover Nuvia wPrime 2A Media, the advanced mixed-mode resin by Bio-Rad for efficient biomolecule purification at small to ...
Enhance compliance and quality in the health and wellness market with Eurofins' GMP certification programme for dietary and ...
Discover key considerations for executing workflows in drug discovery, from defining research questions and generating ...
LB Pharmaceuticals announced positive Phase II results for LB-102, showing significant symptom improvement in schizophrenia with a favourable safety profile. LB Pharmaceuticals, a clinical-stage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback